Are Treatments for HCV Being Over-Promoted? | Hepatitis Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search
Previous

New Hepatitis C Drugs Coming in 2015

Back to News Homepage
Next

Surprising Nutritional Support for Hepatitis C Patients

Are Treatments for HCV Being Over-Promoted?

The Editors at Hepatitis Central
January 26, 2015

Print this page

Learn why the recommended screening for Hepatitis C is being questioned.
Are Treatments for HCV Being Over-Promoted? Pin it on Pinterest

Overdoing Hepatitis C Screenings May Be Bad for your Health

By Dianne Depra, Tech Times | January 15

The Centers for Disease Control and Prevention (CDC) in 2012 recommended hepatitis C screenings for anyone born from 1945 to 1965. In 2014, the World Health Organization made the same recommendation, but a group of scientists are not convinced that mass screenings for the age group are effective or even necessary.

In a piece published in the journal BMJ, Ronald Koretz, Kenneth Lin, John Ioannidis and Jeanne Lenzer questioned the recommended screening for hepatitis C, concerned that it has no basis for clinical harm or benefit for the affected population. Those born between 1945 and 1965 are targeted because around three-quarters of hepatitis C cases occur within the Baby Boomers’ age group.

Continue reading this entire article:
http://www.techtimes.com/articles/26696/20150115/overdoing-hepatitis-c-screenings-may-be-bad-for-your-health.htm

10 Comments
Share
Share
Previous

New Hepatitis C Drugs Coming in 2015

Back to News Homepage
Next

Surprising Nutritional Support for Hepatitis C Patients

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.